inTEST CFO forfeits 4,670 shares to issuer

Q: What insider transaction did inTEST (INTT) CFO Duncan Gilmour report on this Form 4?

CFO Duncan Gilmour reported a disposition of 4,670 inTEST common shares to the company on March 4, 2026. The shares were forfeited under a performance-based restricted stock award originally granted on March 8, 2023, rather than sold on the open market.

Q: How many inTEST (INTT) shares does CFO Duncan Gilmour own after the reported forfeiture?

After the forfeiture, Duncan Gilmour directly holds 56,434 inTEST common shares. In addition, a further 200 common shares are reported as held indirectly by his spouse, giving investors clarity on both his direct and indirect equity interests in the company.

Q: What does the 4,670-share disposition by inTEST (INTT) CFO represent?

The 4,670-share disposition represents shares forfeited back to inTEST Corp under the terms of Gilmour’s performance-based restricted stock award granted on March 8, 2023. This reflects equity award terms, not a cash sale or purchase in the open market.

Q: What stock options does inTEST (INTT) CFO Duncan Gilmour report holding?

Gilmour reports several employee stock options (rights to buy inTEST shares) with different post-transaction amounts. These options vest in four equal annual installments starting on March 9, 2023, March 8, 2024, March 6, 2025 and March 17, 2026, with one grant already fully vested.

Q: How are inTEST (INTT) shares held indirectly by the CFO reported?

The filing shows 200 inTEST common shares held indirectly by Duncan Gilmour’s spouse. These are labeled as indirect ownership "By spouse," helping investors distinguish between his direct holdings in his own name and indirect holdings through a related person.

Q: Does the inTEST (INTT) Form 4 indicate any insider purchases or open-market sales?

This Form 4 reports a disposition to the issuer of 4,670 common shares via forfeiture under a performance-based award. It does not show open-market buys or sells; other entries reflect post-transaction holdings of employee stock options and indirect shares by his spouse.

inTEST Corp CFO Duncan Gilmour reported the disposition of 4,670 shares of common stock to the company on March 4, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

inTEST Corp CFO Duncan Gilmour reported the disposition of 4,670 shares of common stock to the company on March 4, 2026. The shares were forfeited under a performance-based restricted stock award granted on March 8, 2023. After this, he directly holds 56,434 common shares, several employee stock options that vest in four equal annual installments beginning on March 9, 2023, March 8, 2024, March 6, 2025 and March 17, 2026, and 200 common shares held indirectly by his spouse.

Insider Trade Summary

Disposition: 4,670 shares

Disposition 8 txns

Insider Gilmour Duncan

Role CFO, Treasurer & Secretary

Type	Security	Shares	Price	Value
Disposition	Common Stock	4,670	$0.00	$0.00
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Common stock	--	--	--

Holdings After Transaction: Common Stock — 56,434 shares (Direct); Employee Stock Option (right to buy) — 61,789 contracts (Direct); Common stock — 200 shares (Indirect, By spouse)

Footnotes (7)

F1. Shares forfeited under the terms of Mr. Gilmour's performance-based restricted stock award granted on March 8, 2023.
F2. This option vests in four equal annual installments commencing on March 17, 2026.
F3. This option vests in four equal annual installments commencing on March 17, 2026.
F4. This option vests in four equal annual installments commencing on March 6, 2025.
F5. This option vests in four equal annual installments commencing on March 8, 2024.
F6. This option vests in four equal annual installments commencing on March 9, 2023.
F7. This option is fully vested as of the date of this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did inTEST (INTT) CFO Duncan Gilmour report on this Form 4?

CFO Duncan Gilmour reported a disposition of 4,670 inTEST common shares to the company on March 4, 2026. The shares were forfeited under a performance-based restricted stock award originally granted on March 8, 2023, rather than sold on the open market.

How many inTEST (INTT) shares does CFO Duncan Gilmour own after the reported forfeiture?

After the forfeiture, Duncan Gilmour directly holds 56,434 inTEST common shares. In addition, a further 200 common shares are reported as held indirectly by his spouse, giving investors clarity on both his direct and indirect equity interests in the company.

What stock options does inTEST (INTT) CFO Duncan Gilmour report holding?

Gilmour reports several employee stock options (rights to buy inTEST shares) with different post-transaction amounts. These options vest in four equal annual installments starting on March 9, 2023, March 8, 2024, March 6, 2025 and March 17, 2026, with one grant already fully vested.

How are inTEST (INTT) shares held indirectly by the CFO reported?

The filing shows 200 inTEST common shares held indirectly by Duncan Gilmour’s spouse. These are labeled as indirect ownership "By spouse," helping investors distinguish between his direct holdings in his own name and indirect holdings through a related person.

Does the inTEST (INTT) Form 4 indicate any insider purchases or open-market sales?

This Form 4 reports a disposition to the issuer of 4,670 common shares via forfeiture under a performance-based award. It does not show open-market buys or sells; other entries reflect post-transaction holdings of employee stock options and indirect shares by his spouse.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/05/2026 - 04:30 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gilmour Duncan

(Last)

(First)

(Middle)

C/O INTEST CORP

804 EAST GATE DR, SUITE 200

(Street)

MT. LAUREL

08054

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
INTEST CORP [ INTT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO, Treasurer & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/04/2026		D		4,670⁽¹⁾	D	$0	56,434	D
Common stock								200	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$7.74							⁽²⁾	03/16/2035	Common Stock	1,992		1,992	D
Employee Stock Option (right to buy)	$7.74							⁽³⁾	03/16/2035	Common Stock	18,077		18,077	D
Employee Stock Option (right to buy)	$11.33							⁽⁴⁾	03/05/2034	Common Stock	12,724		12,724	D
Employee Stock Option (right to buy)	$16.06							⁽⁵⁾	03/07/2033	Common Stock	8,044		8,044	D
Employee Stock Option (right to buy)	$9.76							⁽⁶⁾	03/08/2032	Common Stock	12,848		12,848	D
Employee Stock Option (right to buy)	$16.8							⁽⁷⁾	06/13/2031	Common Stock	8,104		8,104	D

Explanation of Responses:

1. Shares forfeited under the terms of Mr. Gilmour's performance-based restricted stock award granted on March 8, 2023.

2. This option vests in four equal annual installments commencing on March 17, 2026.

3. This option vests in four equal annual installments commencing on March 17, 2026.

4. This option vests in four equal annual installments commencing on March 6, 2025.

5. This option vests in four equal annual installments commencing on March 8, 2024.

6. This option vests in four equal annual installments commencing on March 9, 2023.

7. This option is fully vested as of the date of this report.

	/s/ Duncan Gilmour	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR